Elevance Health Files 8-K

Ticker: ELV · Form: 8-K · Filed: 2024-05-30T00:00:00.000Z

Sentiment: neutral

Topics: 8-k, reporting

TL;DR

ELEVANCE HEALTH FILES 8-K - STANDARD REPORTING UPDATE

AI Summary

Elevance Health, Inc. filed an 8-K on May 30, 2024, reporting an event that occurred on May 20, 2024. The filing pertains to "Other Events" and "Financial Statements and Exhibits." No specific financial transactions or material events are detailed in the provided text, beyond the standard reporting of these categories.

Why It Matters

This filing indicates Elevance Health is providing updates or disclosures related to its operations and financial reporting, which is standard for public companies.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any immediate negative or positive material events.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Elevance Health?

The provided text does not specify the details of the 'Other Events' beyond listing the category.

What 'Financial Statements and Exhibits' are included in this 8-K filing?

The provided text only lists 'Financial Statements and Exhibits' as an item information category and does not detail the specific contents.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 20, 2024.

What is the principal executive office address for Elevance Health?

The principal executive office address for Elevance Health is 220 Virginia Avenue, Indianapolis, IN 46204.

What is the telephone number provided for Elevance Health?

The telephone number provided for Elevance Health is (833) 401-1577.

From the Filing

0001193125-24-150440.txt : 20240530 0001193125-24-150440.hdr.sgml : 20240530 20240530164502 ACCESSION NUMBER: 0001193125-24-150440 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20240520 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 241006179 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 d819869d8k.htm 8-K 8-K false 0001156039 0001156039 2024-05-20 2024-05-20     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 ( May 20, 2024 )     Elevance Health, Inc. (Exact name of registrant as specified in its charter)       Indiana   001-16751   35-2145715 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 220 Virginia Avenue Indianapolis , IN 46204 (Address of principal executive offices) (Zip Code) (833) 401-1577 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ELV   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01 Other Events. The Notes Offering On May 30, 2024, Elevance Health, Inc. (formerly known as Anthem, Inc.) (the “Company”) closed its sale of $600 million aggregate principal amount of its 5.150% Notes due 2029 (the “2029 Notes”), $1,000 million aggregate principal amount of its 5.375% Notes due 2034 (the “2034 Notes”) and $1,000 million aggregate principal amount of its 5.650% Notes due 2054 (the “2054 Notes” and, together with the 2029 Notes and the 2034 Notes,

View on Read The Filing